| Date | Company | Amount | Funding type | Investors | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2015-02-05 | Plasticell (UK) | £1.3 million | grant | Innovate UK (UK) | Technology - Services - Regenerative medicine | Grant |
| 2015-02-05 | Thrombogenics (Belgium) | €1.1 million | grant | Flemish Agency for Innovation by Science and Technology (IWT) (Belgium) | Ophtalmological diseases | Grant |
| 2015-02-05 | Bind Therapeutics (USA - MA) | $21.5 million | private placement | Cancer - Oncology | Private placement | |
| 2015-02-04 | Capricor Therapeutics (USA - CA) | $ 7 million | financing round | Broadfin Capital (USA - NY) Sabby Capital (USA - NJ) CureDuchenne Ventures (USA - CA) | Cardiovascular diseases | Financing round |
| 2015-02-02 | Ascendis Pharma (Denmark) | $111.5 million | IPO | IPO | ||
| 2015-02-02 | Motif Bio (UK) | £4 million (€ 5.33 million) | IPO | Infectious diseases | IPO | |
| 2015-01-29 | Verastem (USA - CA) | $50.9 million | private placement | Cancer - Oncology | Private placement | |
| 2015-01-27 | TxCell (France) | € 1.7 million | loan | BpiFrance (France) | Autoimmune diseases - Inflammatory diseases - Digestive diseases | Loan |
| 2015-01-26 | Acticor Biotech (France) | € 0.59 million | capital increase | investors of the French equity crowdfunding platform Anaxago (France) and business angels | Cardiovascular diseases - Cerebrovascular diseases | Capital increase |
| 2015-01-23 | Bind Therapeutics (USA - MA) | $15 million | loan | Hercules Technology Growth Capital (USA - CA) | Cancer - Oncology | Loan |
| 2015-01-22 | Autolus (UK) | £30 million | series A financing round | Syncona (UK) | Cancer - Oncology | Series A financing round |
| 2015-01-21 | Alnylam Pharmaceuticals (USA - MA) | $496.4 million | private placement | Private placement | ||
| 2015-01-21 | RegenXBio (USA - MD) | $30 million | series C financing round | Venrock (USA - CA) Brookside Capital (USA - MA) Deerfield Management (USA - NY) FoxKiser (USA - WA) Fidelity BioSciences (USA - MA) unnamed new investor | Rare diseases - Genetic diseases | Series C financing round |
| 2015-01-20 | Arena Pharmaceuticals (USA - CA) | private placement | Private placement | |||
| 2015-01-20 | Gecko Biomedical (France) | € 1.3 million | loan | BpiFrance (France) | Medical devices | Loan |
| 2015-01-19 | NovaBiotics (UK) | £5 million | private placement | Woodford Investment Management | Infectious diseases | Private placement |
| 2015-01-19 | Theravectys (France) | €1.9 million | grant | BpiFrance (France) | Cancer - Oncology - Infectious diseases | Grant |
| 2015-01-19 | Sensorion (France) | €4 million | financing round | Innobio (France) Inserm Transfert Initiative (France) | Otorhinolaryngology | Financing round |
| 2015-01-14 | Alcobra (Israel) | $27.9 million | private placement | Venrock (USA - CA), Deerfield (USA - NY), Broadfin Capital (USA - NY), Great Point Partners (USA - CT) | CNS diseases - Mental diseases - Genetic diseases - Rare diseases | Private placement |
| 2015-01-13 | Cempra (USA - NC) | $120.6 million | private placement | Infectious diseases | Private placement |
